Clinical practice guidelines for therapeutic drug monitoring of vancomycin in the framework of model-informed precision dosing: a consensus review by the Japanese …

K Matsumoto, K Oda, K Shoji, Y Hanai, Y Takahashi… - Pharmaceutics, 2022 - mdpi.com
Background: To promote model-informed precision dosing (MIPD) for vancomycin (VCM),
we developed statements for therapeutic drug monitoring (TDM). Methods: Ten clinical …

[HTML][HTML] Clinical practice guideline for the therapeutic drug monitoring of voriconazole in non-Asian and Asian adult patients: consensus review by the Japanese …

Y Takesue, Y Hanai, K Oda, Y Hamada, T Ueda… - Clinical Therapeutics, 2022 - Elsevier
Purpose Voriconazole, an antifungal drug, is metabolized by a cytochrome P450 isozyme.
Increased adverse effects are observed in Asians because of the high rate of poor …

A hybrid machine learning/pharmacokinetic approach outperforms maximum a posteriori Bayesian estimation by selectively flattening model priors

JH Hughes, RJ Keizer - CPT: pharmacometrics & systems …, 2021 - Wiley Online Library
Abstract Model‐informed precision dosing (MIPD) approaches typically apply maximum a
posteriori (MAP) Bayesian estimation to determine individual pharmacokinetic (PK) …

[HTML][HTML] Precision dosing software to optimize antimicrobial dosing: a systematic search and follow-up survey of available programs

NGL Jager, MG Chai, RM van Hest, J Lipman… - Clinical Microbiology …, 2022 - Elsevier
Background Precision dosing programs are promising tools for optimising antimicrobial
dosing. Selecting the ideal program for local application may be challenging due to the large …

Pharmacokinetics of antibiotics in pediatric intensive care: fostering variability to attain precision medicine

M Gijsen, D Vlasselaers, I Spriet, K Allegaert - Antibiotics, 2021 - mdpi.com
Children show important developmental and maturational changes, which may contribute
greatly to pharmacokinetic (PK) variability observed in pediatric patients. These PK …

Barriers and facilitators in the clinical implementation of beta-lactam therapeutic drug monitoring in critically ill patients: a critical review

A Abdulla, P van den Broek, TMJ Ewoldt… - Therapeutic Drug …, 2022 - journals.lww.com
Background: With increasing knowledge of beta-lactam pharmacodynamics and interpatient
and intrapatient variability in pharmacokinetics, the usefulness of therapeutic drug …

Aminoglycosides-Related Ototoxicity: Mechanisms, Risk Factors, and Prevention in Pediatric Patients

S Rivetti, A Romano, S Mastrangelo, G Attinà… - Pharmaceuticals, 2023 - mdpi.com
Aminoglycosides are broad-spectrum antibiotics largely used in children, but they have
potential toxic side effects, including ototoxicity. Ototoxicity from aminoglycosides is …

Optimizing antimicrobial therapy by integrating multi-omics with pharmacokinetic/pharmacodynamic models and precision dosing

HY Yow, K Govindaraju, AH Lim… - Frontiers in …, 2022 - frontiersin.org
In the era of “Bad Bugs, No Drugs,” optimizing antibiotic therapy against multi-drug resistant
(MDR) pathogens is crucial. Mathematical modelling has been employed to further optimize …

Knowledge gaps in late-onset neonatal sepsis in preterm neonates: a roadmap for future research

S Kurul, K Fiebig, RB Flint, IKM Reiss, H Küster… - Pediatric …, 2022 - nature.com
Late-onset neonatal sepsis (LONS) remains an important threat to the health of preterm
neonates in the neonatal intensive care unit. Strategies to optimize care for preterm …

Bayesian prediction-based individualized dosing of anti-methicillin-resistant Staphylococcus aureus treatment: recent advancements and prospects in therapeutic …

K Oda, H Saito, H Jono - Pharmacology & Therapeutics, 2023 - Elsevier
As one of the efficient techniques for TDM, the population pharmacokinetic (popPK) model
approach for dose individualization has been developed due to the rapidly growing …